Rescue of HSV-1 neurovirulence is associated with induction of brain interleukin-1 expression, prostaglandin synthesis and neuroendocrine responses

References

• Antoni F A. Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocrine Rev 1986; 7: 351–378
   PubMed Web of Science ®Google Scholar
• Ban E, Haour F, Lenstra R. Brain interleukin 1 gene expression induced by peripheral lipopolysaccharide administration. Cytokine 1992; 4: 48–54
   PubMed Web of Science ®Google Scholar
• Becker Y, Hadar J, Tabor E, Ben-Hur T, Raibstein I, Rosen A, Darai G. A sequence in Hpal-P fragment of herpes simplex virus-1 DNA determines intraperitoneal virulence in mice. Virology 1986; 149: 255–259
   PubMed Web of Science ®Google Scholar
• Ben-Hur T, Hadar J, Shtram Y, Gilden D H, Becker Y. Neurovirulence of herpes simplex virus type 1 depends on age in mice and thymidine kinase expression. Arch Virol 1983; 78: 303–308
   Google Scholar
• Ben-Hur T, Asher Y, Tabor E, Darai G, Becker Y. HSV-1 virulence for mice by the intracerebral route is encoded by the BamHI-L DNA fragment containing the cell fusion gene. Arch Virol 1987; 96: 117–122
   Google Scholar
• Ben-Hur T, Rosen-Wolff A, Lamade W, Darai G, Becker Y. HSV-1 DNA sequence determining intraperitoneal pathogenicity in mice is required for transcription of viral immediate early genes in macrophages. Virology 1988; 163: 397–404
   Google Scholar
• Ben-Hur T, Conforti N, Itzik A, Weidenfeld J. Effects of HSV-1, a neurotropic virus, on the hypothalamic-pituitary-adrenocortical axis in rats. Brain Res 1995; 702: 17–22
   Google Scholar
• Bond V C, Person S. Fine structure physical map locations of alterations that affect cell fusion in herpes simplex virus type 1. Virology 1984; 132: 368–376
   PubMedGoogle Scholar
• Chirgwin J M, Pryzbyla A E, MacDonald R S, Rutter W S. Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry 1979; 18: 5294–5299
   PubMed Web of Science ®Google Scholar
• Chou J, Kern E R, Whitley R J, Roizman B. Mapping of herpes simplex virus-1 neurovirulence to 134.5, a gene nonessential for growth in culture. Science 1990; 250: 1262–1266
   PubMed Web of Science ®Google Scholar
• Dallman M F, Akana S F, Cascio C S, Darlington D N, Jacobson L, Levin N. Regulation of ACTH secretion: Variation of a theme of B. Prog Horm Res 1987; 43: 113–173
   PubMedGoogle Scholar
• Day S P, Lausch R N, Oakes J E. Evidence that the gene for the herpes simplex virus type 1 DNA polymerase accounts for the capacity of an intertypic recombinant to spread from eye to central nervous system. Virology 1988; 163: 166–173
   PubMed Web of Science ®Google Scholar
• Field H J, Coen D M. Pathogenicity of herpes simplex virus mutants containing drug resistance mutations in the viral DNA polymerase gene. J Virol 1986; 60: 286–289
   PubMedGoogle Scholar
• Field H J, Wildy P. The pathogenicity of thymidine kinase - deficient mutants of herpes simplex virus in mice. J Hyg (Cambridge) 1978; 81: 267–277
   PubMedGoogle Scholar
• Fuller R W. The involvement of serotonin in regulation of pituitary-adrenocortical function. Frontier in Neuroendocrinology 1992; 13: 250–270
   Web of Science ®Google Scholar
• Giulian D, Corpuz M. Microglial secretion products and their impact on the nervous system. Adv Neurol 1993; 59: 315–320
   Google Scholar
• Gordon Y, Gilden D H, Shtram Y, Asher Y, Tabor E, Wellish M, Devlin M, Snipper D, Hadar J, Becker Y. A low thymidine kinase producing mutant of herpes simplex virus type 1 causes latent trigeminal ganglia infections in mice. Arch Virol 1983; 76: 39–49
   PubMedGoogle Scholar
• Hopkins S J, Rothwell N J. Cytokines and the nervous system I: expression and regulation. Trends Neurosci 1995; 18: 83–88
   PubMed Web of Science ®Google Scholar
• Hutchinson L, Goldsmith K, Snoddy D, Ghosh H, Graham F L, Johnson D C. Identification and characterization of a novel herpes simplex glycoprotein, gK, involved in cell fusion. J Virol 1992; 66: 5603–5609
   PubMed Web of Science ®Google Scholar
• Izumi K M, Stevens J G. Molecular and biological characterization of a herpes simplex virus type 1 (HSV-1) neuroinvasiveness gene. J Exp Med 1990; 172: 487–496
   PubMed Web of Science ®Google Scholar
• Javier R T, Izumi K M, Stevens J G. Localization of a herpes simplex virus neurovirulence gene dissociated from high-titer virus replication in the brain. J Virol 1988; 62: 1381–1387
   Google Scholar
• Kapas L, Shibata M, Kimura M, Krueger J M. Inhibition of nitric oxide synthesis suppresses sleep in rabbits. Am J Physiol 1994; 266: R151–R157
   Google Scholar
• Knudsen P S, Dinarello C A, Strom T B. Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. J Immunol 1987; 139: 4129–4134
   PubMed Web of Science ®Google Scholar
• Lew W, Oppenheim J J, Matsushima K. Analysis of the suppression of IL-la and IL-1β production in human peripheral blood mononuclear adherent cells by glucocorticoid hormone. J Immunol 1988; 140: 1895–1902
   PubMed Web of Science ®Google Scholar
• Liebermann A P, Pitha P M, Shin H S, Shin M L. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci USA 1989; 86: 6348–6352
   Google Scholar
• Meignier M, Longnecker R, Mavromara-Nazos P, Sears A, Roizman B. Virulence of and establishment of latency by genetically engineered deletion mutants of herpes simplex virus 1. Virology 1988; 162: 251–254
   PubMed Web of Science ®Google Scholar
• Moyal M, Berkowitz C, Rosen-Wolff A, Darai G, Becker Y. Mutations in the UL53 gene of HSV-1 abolish virus neurovirulence to mice by the intracerebral route of injection. Virus Res 1992; 26: 99–112
   Google Scholar
• Pellegrino L J, Pellegrino A S, Cushman A JA. A stereotaxic atlas of the rat brain. Plenumk, New York 1967; 1967
   Google Scholar
• Plotsky P M, Cunningham E T, Widmaier E P. Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endocrine Rev 1989; 10: 437–458
   PubMed Web of Science ®Google Scholar
• Pogue-Geile K L, Lee G T-Y, Shapira S K, Spear P G. Fine mapping of mutations in the fusion-inducing MP strain of herpes simplex virus type 1. Virology 1984; 136: 100–109
   PubMedGoogle Scholar
• Roizman B, Kaplan L J. Herpes simplex viruses, central nervous system, and encephalitis: A two-body problem, with one outcome and too many questions. Molecular neurovirology, P. Roos Raymond. Humana press, Totowa, New Jersey 1992; 3–24
   Google Scholar
• Rosen A, Gelderblom H, Darai G. Transduction of virulence in herpes simplex virus type 1 from a pathogenic to an apathogenic strain by a cloned viral DNA fragment. Med Microbiol Immunol 1985; 173: 257–278
   PubMedGoogle Scholar
• Rothwell N J, Hopkins S J. Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci 1995; 18: 130–136
   PubMed Web of Science ®Google Scholar
• Rothwell N J, Relton J K. Involvement of cytokines in acute neurodegeneration in the CNS. Neurosci Biobehav Rev 1993; 17: 217–227
   PubMed Web of Science ®Google Scholar
• Ruyechan W T, Morse L S, Knipe D M, Roizman B. Molecular genetics of herpes simplex virus. II. Mapping of the major viral glycoproteins and of the genetic loci specifying the social behavior of infected cells. J Virol 1979; 29: 677–687
   PubMedGoogle Scholar
• Schobitz B, De Kloet E R, Holsboer F. Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain. Prog Neurobiol 1994; 44: 397–432
   PubMed Web of Science ®Google Scholar
• Thomas P S. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci USA 1980; 71: 5201–5205
   Google Scholar
• Thompson R L, Wagner E K, Stevens J G. Physical location of a herpes simplex virus type 1 gene function(s) specifically associated with a 10 million fold increase in HSV neurovirulence. Virology 1983; 131: 180–192
   PubMedGoogle Scholar
• Thompson R L, Devi-Rao G V, Stevens J G, Wagner E K. Rescue of a herpes simplex virus type 1 neurovirulence function with a cloned DNA fragment. J Virol 1985; 55: 504–508
   PubMedGoogle Scholar
• Waage A, Halstensen A, Shakaby R, Brandtxaeg P, Kierulf P, Espevik T. Local production of tumor necrosis factor alpha, interleukin 1 and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J Exp Med 1989; 170: 1859–1867
   PubMed Web of Science ®Google Scholar
• Weidenfeld J, Rougeot C, Dray F, Feldman S. Adrenocortical response following acute neurogenic stimuli is mediated by CRF-41. Neurosci Lett 1989; 107: 189–194
   Google Scholar
• Weidenfeld J, Kahbha K, Reches A, Shohami E. Role of the central adrenergic system in the regulation of prostaglandin biosynthesis in rat brain. J Neurochem 1992; 58: 694–699
   PubMedGoogle Scholar
• Weidenfeld J, Feldman S. Glucocorticoid feedback regulation of adrenocortical responses to neural stimuli: role of CRF-41 and corticosteroid type I and type II receptors. Neuroendocrinology 1993; 58: 49–56
   Google Scholar
• Whitnall M H. Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Progress in Neurobiol 1993; 40: 573–629
   PubMed Web of Science ®Google Scholar
• Yan H Q, Banos M A, Herregodts P, Hooghe R, Hooghe-Peters E L. Expression of interleukin (IL)-l beta, IL-6 and their respective receptors in the normal rat brain and after injury. Eur J Immunol 1992; 22: 2963–2971
   PubMed Web of Science ®Google Scholar